braltus 10 mikrogram inhalationspulver, hård kapsel
teva b.v. - tiotropiumbromid - inhalationspulver, hård kapsel - 10 mikrogram
tavulus 18 mikrogram inhalationspulver, hård kapsel
glenmark pharmaceuticals nordic ab - tiotropiumbromid - inhalationspulver, hård kapsel - 18 mikrogram
spiriva 18 mikrogram inhalationspulver, hård kapsel
boehringer ingelheim int. gmbh - tiotropiumbromidmonohydrat - inhalationspulver, hård kapsel - 18 mikrogram
spiriva 18 mikrogram inhalationspulver, hård kapsel
orifarm a/s - tiotropium bromid - inhalationspulver, hård kapsel - 18 mikrogram
spiriva 18 mikrogram inhalationspulver, hård kapsel
paranova danmark a/s - tiotropium bromid - inhalationspulver, hård kapsel - 18 mikrogram
srivasso 18 mikrogram inhalationspulver, hård kapsel
2care4 aps - tiotropiumbromidmonohydrat - inhalationspulver, hård kapsel - 18 mikrogram
srivasso 18 mikrogram inhalationspulver, hård kapsel
orifarm a/s - tiotropiumbromidmonohydrat - inhalationspulver, hård kapsel - 18 mikrogram
eloxatin 5 mg/ml koncentrat til infusionsvæske, opløsning
sanofi-aventis denmark a/s - oxaliplatin - koncentrat til infusionsvæske, opløsning - 5 mg/ml
oxaliplatin "hospira" 5 mg/ml koncentrat til infusionsvæske, opløsning
hospira uk limited - oxaliplatin - koncentrat til infusionsvæske, opløsning - 5 mg/ml
kymriah
novartis europharm limited - tisagenlecleucel - precursor b-cell lymphoblastic leukemia-lymphoma; lymphoma, large b-cell, diffuse - andre antineoplastiske midler - kymriah is indicated for the treatment of:• paediatric and young adult patients up to and including 25 years of age with b cell acute lymphoblastic leukaemia (all) that is refractory, in relapse post transplant or in second or later relapse. • adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl) after two or more lines of systemic therapy. • adult patients with relapsed or refractory follicular lymphoma (fl) after two or more lines of systemic therapy.